Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
ELISA Kit for Orosomucoid 2 (ORM2)
AGP-B; AGP2; Alpha-1-Acid Glycoprotein Type 2
- Product No.SEB780Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample Typeserum, plasma and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length3h
- Detection Range3.12-200ng/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 1.29ng/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 466
For more details, please contact local distributors! US$ 665 US$ 2993 US$ 5653 US$ 46550
Specificity
This assay has high sensitivity and excellent specificity for detection of Orosomucoid 2 (ORM2).
No significant cross-reactivity or interference between Orosomucoid 2 (ORM2) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Orosomucoid 2 (ORM2) and the recovery rates were calculated by comparing the measured value to the expected amount of Orosomucoid 2 (ORM2) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 82-105 | 101 |
EDTA plasma(n=5) | 82-96 | 92 |
heparin plasma(n=5) | 95-105 | 101 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Orosomucoid 2 (ORM2) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Orosomucoid 2 (ORM2) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Orosomucoid 2 (ORM2) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 84-99% | 81-90% | 95-103% | 78-96% |
EDTA plasma(n=5) | 91-99% | 78-97% | 78-94% | 84-96% |
heparin plasma(n=5) | 94-102% | 87-96% | 92-101% | 90-97% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.
GIVEAWAYS
INCREMENT SERVICES
- Single-component Reagents of Assay Kit
- Lysis Buffer Specific for ELISA / CLIA
- Quality Control of Kit
- ELISA Kit Customized Service
- Disease Model Customized Service
- Serums Customized Service
- TGFB1 Activation Reagent
- Real Time PCR Experimental Service
- Streptavidin
- Fast blue Protein Stain solution
- Single-component Reagents of FLIA Kit
- Streptavidin-Agarose Beads
Magazine | Citations |
Clin Exp Nephrol | Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome PubMed: 26351173 |
Free Patents online | RHEUMATOID ARTHRITIS RELATED BIOMARKER 20170350884 |
Osteoarthritis and Cartilage | Orosomucoid 2 serves for predicting but not for monitoring drug response in patients with knee osteoarthritis treated with chondroitin sulfate/glucosamine … 10.1016:j.joca.2018.02.412 |
Therapeutic Advances in Chronic Disease | Predictive modeling of therapeutic response to chondroitin sulfate/glucosamine hydrochloride in knee osteoarthritis |
Journal of Cosmetic Dermatology | Evaluation of serum and urinary orsomucoid protein A in psoriatic patients and their relation to severity of disease 33905172 |
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
RPB780Hu01 | Recombinant Orosomucoid 2 (ORM2) | Positive Control; Immunogen; SDS-PAGE; WB. |
CPB780Hu21 | OVA Conjugated Orosomucoid 2 (ORM2) | Immunogen; SDS-PAGE; WB. |
PAB780Hu01 | Polyclonal Antibody to Orosomucoid 2 (ORM2) | WB; IHC; ICC; IP. |
LAB780Hu81 | FITC-Linked Polyclonal Antibody to Orosomucoid 2 (ORM2) | WB; IHC; ICC; IF. |
LAB780Hu71 | Biotin-Linked Polyclonal Antibody to Orosomucoid 2 (ORM2) | WB; IHC; ICC. |
MAB780Hu22 | Monoclonal Antibody to Orosomucoid 2 (ORM2) | WB; IHC |
MAB780Hu21 | Monoclonal Antibody to Orosomucoid 2 (ORM2) | WB; IHC; ICC; IP. |
SEB780Hu | ELISA Kit for Orosomucoid 2 (ORM2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB780Hu | Multiplex Assay Kit for Orosomucoid 2 (ORM2) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |